サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1739251

睡眠補助製品の世界市場

Sleep Aids

出版日
ページ情報
英文 282 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.36円
睡眠補助製品の世界市場
出版日: 2025年05月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 282 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

睡眠補助製品の世界市場は2030年までに1,108億米ドルに達する見込み

2024年に754億米ドルと推定される睡眠補助製品の世界市場は、2024年から2030年にかけてCAGR 6.6%で成長し、2030年には1,108億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである医薬品は、CAGR 8.0％を記録し、分析期間終了時には566億米ドルに達すると予測されます。睡眠時無呼吸症候群治療器（Sleep Apnea Devices）分野の成長率は、分析期間中CAGR 4.4％と推定されます。

米国市場は205億米ドル、中国はCAGR 10.7％で成長予測

米国の睡眠補助製品市場は2024年に205億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに232億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.5%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の「睡眠補助製品」市場- 主要動向と促進要因のまとめ

現代社会で睡眠補助製品の需要が急増している理由とは？

睡眠補助製品は、不眠症、睡眠時無呼吸症候群、ナルコレプシーから概日リズムの乱れやレストレスレッグ症候群に至るまで、世界的に蔓延している睡眠障害と闘う上で不可欠なツールとなっています。ストレスレベルの上昇、スクリーンタイム、不規則な労働時間、睡眠衛生状態の悪化などの要因により、急性および慢性の睡眠問題の発生率が世界的に著しく増加しています。世界保健機関（WHO）によると、世界人口の3分の1近くが何らかの睡眠障害に悩まされており、睡眠の健康は公衆衛生の重要な要素となっています。睡眠補助製品-医薬品、天然サプリメント、睡眠導入装置、行動療法ツールなど、健康的な睡眠パターンを回復・調整するためのさまざまな選択肢があります。現代の消費者は、不眠症の解消を求めるだけでなく、パフォーマンスの最適化、より良い精神状態、全人的な健康状態を求めており、これらすべてが睡眠の質と複雑に関連しています。睡眠がウェルネス・ナラティブの中心となるにつれ、睡眠補助製品の役割は消極的な治療から積極的なライフスタイル管理へと進化しています。このシフトは、年齢層、所得層、地域を問わず、大規模な市場拡大に拍車をかけています。時差ぼけのエグゼクティブから高齢者、不安な10代の若者まで、睡眠補助製品は今や、人間の普遍的なニーズに対する実用的で利用しやすいソリューションとみなされています。

睡眠テクノロジーとサプリメントの革新は、回復睡眠をどのように再定義しているのでしょうか？

睡眠補助製品市場は、より良い睡眠への非侵襲的、薬物不使用、個別化されたアプローチを提供することを目的とした、技術的、生化学的革新の波によって再形成されつつあります。ウェアラブル・トラッカー、スマート・マットレス、脳波ヘッドバンドなどのスマート睡眠デバイスは、生体センサーとAIアルゴリズムを使って睡眠サイクルをリアルタイムでモニターし、最適化します。ホワイトノイズマシン、概日照明システム、睡眠誘導アプリは、自然なメラトニンの生成と入眠をサポートする環境作りに役立っています。医薬品の面では、オレキシン受容体拮抗薬（スボレキサントなど）のような新世代の催眠薬は、旧来の鎮静薬よりも依存リスクが少なく、的を絞った睡眠調節を提供します。一方、栄養補助食品分野は、メラトニン、マグネシウム、バレリアンルート、L-テアニン、CBDベースの睡眠サプリメントに対する需要の増加で活況を呈しています。機能性飲料や睡眠グミは、特にミレニアル世代やZ世代の間で、消費者に親しみやすい提供形態として台頭しています。企業はまた、睡眠コーチングアプリや、現在では金字塔的治療法として認知されている不眠症の認知行動療法（CBT-I）を提供する遠隔医療プラットフォームにも投資しています。これらのイノベーションは、ホリスティックでデータ主導型の副作用のないソリューションへの嗜好の高まりを反映しており、睡眠補助製品市場は症状管理から包括的な睡眠最適化へとシフトしています。

睡眠補助製品は、人口統計、健康分野、世界各地のどこで価値を創造していますか？

睡眠補助製品は、幅広い使用事例や集団において、測定可能な価値を生み出しています。慢性疾患や薬の相互作用で睡眠が分断されがちな高齢者では、睡眠補助製品は認知機能や感情的な幸福を維持するために非常に重要です。社会人、特に交代勤務者や出張の多い人においては、睡眠ソリューションは疲労を軽減し、生産性を高め、メンタルヘルスをサポートするために不可欠です。思春期の若者や大学生は、不安やハイテク機器への過剰な露出、学業ストレスの影響を受けつつあり、睡眠アプリやブルーライト遮断ソリューション、自然療法に注目しています。臨床の場では、うつ病、PTSD、ADHD、アルツハイマー病などの神経変性疾患の患者に併存する睡眠障害の治療に、睡眠補助製品が重要な役割を果たしています。ウェルネス産業では、フィットネストラッカー、メンタルウェルネスサブスクリプション、スパトリートメントなど、個別化された健康パッケージに睡眠ソリューションがバンドルされています。地理的には、認知度の高さ、保険適用範囲、高度なヘルスケア・インフラにより、北米が市場を独占しています。しかし、可処分所得の増加、都市化、睡眠時無呼吸症候群や不眠症の診断増加により、アジア太平洋が高成長地域として浮上しています。欧州や中東の睡眠研究所、病院睡眠センター、小売薬局も、睡眠補助薬の提供を拡大しています。臨床治療から消費者の健康管理まで、このように幅広い分野で採用されていることが、今日の健康重視文化における睡眠補助製品の多用途性と関連性を裏付けています。

睡眠補助製品市場の成長は、ライフスタイルの変化、医療ニーズ、消費者の嗜好、技術的アクセスを反映するいくつかの要因によって牽引されています。

主な成長要因の1つは、現代的なライフスタイルのストレス要因、精神的健康状態、肥満や糖尿病などの身体的併存疾患によって、睡眠障害の有病率が増加していることです。また、睡眠不足が免疫力、心臓の健康、精神的パフォーマンスに長期的な影響を及ぼすという認識の高まりも、個人を早期介入へと向かわせています。処方箋を必要としない、自然で薬剤を使わない代替品への需要が、栄養補助食品とウェルネス分野の技術革新に拍車をかけており、CBDベースの睡眠ソリューションに対する規制当局の支援が新市場を開拓しています。ウェアラブル・テクノロジーや健康に特化したモバイル・アプリの台頭により、特にテクノロジーに精通した層の間では、睡眠の追跡と最適化がより身近なものとなっています。CBT-Iを提供する遠隔医療プラットフォームは、地方や十分なサービスを受けていない地域におけるエビデンスに基づく治療へのアクセスを拡大しています。職場においては、従業員の福利厚生に対する投資の高まりが、睡眠教育・支援ツールの企業導入に拍車をかけています。薬局、eコマース、ウェルネス・プラットフォームを通じた小売販売により製品へのアクセスが拡大する一方、積極的なマーケティングやインフルエンサー主導の啓発キャンペーンにより消費者の関心が高まっています。さらに、ヘルスケアコストの上昇と予防医療へのシフトが、消費者にウェルネスの基礎となる睡眠管理への投資を促しています。医療、技術、行動、経済など、相互に関連するこれらの促進要因が、世界の睡眠補助製品市場の急速かつ多次元的な成長を後押ししています。

セグメント

製品タイプ（薬、睡眠時無呼吸症候群用デバイス、マットレス＆枕、その他の製品タイプ）、睡眠障害（不眠症、睡眠時無呼吸症候群、むずむず脚症候群、夜驚症、その他の睡眠障害）

調査対象企業の例（全36件）

  • AstraZeneca Plc
  • BMC Medical Co., Ltd.
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Ltd.
  • GlaxoSmithKline Plc
  • Idorsia Pharmaceuticals Ltd.
  • Itamar Medical Ltd.
  • Koninklijke Philips N.V.
  • LG Electronics Inc.
  • Merck & Co., Inc.
  • Natus Medical Incorporated
  • Novartis AG
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.
  • SleepMed Inc.
  • Teva Pharmaceutical Industries Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34344

Global Sleep Aids Market to Reach US$110.8 Billion by 2030

The global market for Sleep Aids estimated at US$75.4 Billion in the year 2024, is expected to reach US$110.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Medications, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$56.6 Billion by the end of the analysis period. Growth in the Sleep Apnea Devices segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.5 Billion While China is Forecast to Grow at 10.7% CAGR

The Sleep Aids market in the U.S. is estimated at US$20.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$23.2 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global "Sleep Aids" Market - Key Trends & Drivers Summarized

Why Is The Demand For Sleep Aids Skyrocketing In Modern Societies?

Sleep aids have become essential tools in combating the global epidemic of sleep disorders-ranging from insomnia, sleep apnea, and narcolepsy to circadian rhythm disruptions and restless leg syndrome. Factors such as rising stress levels, screen time, erratic work hours, and poor sleep hygiene have significantly increased the incidence of both acute and chronic sleep issues worldwide. According to the World Health Organization, nearly one-third of the global population suffers from some form of sleep disturbance, making sleep health a critical component of public wellness. Sleep aids-encompassing pharmaceuticals, natural supplements, sleep-inducing devices, and behavioral therapy tools-offer varied options to restore and regulate healthy sleep patterns. Modern consumers are not only looking for relief from insomnia but also seeking performance optimization, better mental health, and holistic well-being-all of which are intricately tied to sleep quality. As sleep becomes central to the wellness narrative, the role of sleep aids has evolved from reactive treatment to proactive lifestyle management. This shift is fueling massive market expansion across age groups, income segments, and global geographies. From jet-lagged executives to aging adults and anxious teens, sleep aids are now seen as practical, accessible solutions to a universal human need.

How Are Innovations In Sleep Technology And Supplements Redefining Restorative Sleep?

The sleep aids market is being reshaped by a wave of technological and biochemical innovations aimed at offering non-invasive, drug-free, and personalized approaches to better sleep. Smart sleep devices-such as wearable trackers, smart mattresses, and brainwave headbands-use biometric sensors and AI algorithms to monitor and optimize sleep cycles in real time. White noise machines, circadian lighting systems, and guided sleep apps are helping to create ambient environments that support natural melatonin production and sleep onset. On the pharmaceutical front, newer-generation hypnotics like orexin receptor antagonists (e.g., suvorexant) provide targeted sleep regulation with fewer dependency risks than older sedatives. Meanwhile, the nutraceutical segment is booming with increased demand for melatonin, magnesium, valerian root, L-theanine, and CBD-based sleep supplements, driven by their over-the-counter availability and lower side-effect profiles. Functional beverages and sleep gummies are emerging as consumer-friendly delivery formats, especially among millennials and Gen Z. Companies are also investing in sleep coaching apps and telehealth platforms that offer cognitive behavioral therapy for insomnia (CBT-I), now recognized as a gold-standard treatment. These innovations reflect a growing preference for holistic, data-driven, and side-effect-free solutions-shifting the sleep aids market from symptom management to comprehensive sleep optimization.

Where Are Sleep Aids Creating Value Across Demographics, Health Sectors, And Global Regions?

Sleep aids are generating measurable value across a wide spectrum of use cases and populations. In the elderly, where sleep fragmentation is common due to chronic conditions and medication interactions, sleep aids are crucial for maintaining cognitive function and emotional well-being. In working adults, particularly shift workers and frequent travelers, sleep solutions are vital for reducing fatigue, enhancing productivity, and supporting mental health. Adolescents and college students, increasingly affected by anxiety, tech overexposure, and academic stress, are turning to sleep apps, blue-light-blocking solutions, and natural remedies. In clinical settings, sleep aids play a critical role in treating comorbid sleep disorders in patients with depression, PTSD, ADHD, and neurodegenerative diseases like Alzheimer’s. In the wellness industry, sleep solutions are being bundled into personalized health packages, including fitness trackers, mental wellness subscriptions, and spa treatments. Geographically, North America dominates the market due to high awareness, insurance coverage, and advanced healthcare infrastructure. However, Asia-Pacific is emerging as a high-growth region due to rising disposable income, urbanization, and increased diagnoses of sleep apnea and insomnia. Sleep labs, hospital sleep centers, and retail pharmacies across Europe and the Middle East are also expanding sleep aid offerings. This widespread adoption across sectors-from clinical therapy to consumer wellness-underscores sleep aids’ versatility and relevance in today’s health-focused culture.

The Growth In The Sleep Aids Market Is Driven By Several Factors That Reflect Shifting Lifestyles, Medical Needs, Consumer Preferences, And Technological Access

One of the primary growth drivers is the increasing prevalence of sleep disorders, driven by modern lifestyle stressors, mental health conditions, and physical comorbidities like obesity and diabetes. Growing awareness of the long-term impact of poor sleep on immunity, heart health, and mental performance is also pushing individuals toward early intervention. Demand for non-prescription, natural, and drug-free alternatives is fueling innovation in the nutraceutical and wellness segments, while regulatory support for CBD-based sleep solutions is opening new markets. The rise in wearable technology and health-focused mobile apps has made sleep tracking and optimization more accessible, especially among tech-savvy demographics. Telemedicine platforms offering CBT-I are expanding access to evidence-based therapy in rural and underserved regions. In the workplace, rising investments in employee well-being are spurring corporate adoption of sleep education and support tools. Retail availability through pharmacies, e-commerce, and wellness platforms is expanding product reach, while aggressive marketing and influencer-led awareness campaigns are amplifying consumer engagement. Additionally, rising healthcare costs and the shift toward preventive health are prompting consumers to invest more in sleep management as a foundational wellness practice. These interconnected drivers-medical, technological, behavioral, and economic-are collectively powering the rapid and multidimensional growth of the global sleep aids market.

SCOPE OF STUDY:

The report analyzes the Sleep Aids market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Medications, Sleep Apnea Devices, Mattresses & Pillows, Other Product Types); Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors, Other Sleep Disorders)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AstraZeneca Plc
  • BMC Medical Co., Ltd.
  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co., Ltd.
  • Fisher & Paykel Healthcare Ltd.
  • GlaxoSmithKline Plc
  • Idorsia Pharmaceuticals Ltd.
  • Itamar Medical Ltd.
  • Koninklijke Philips N.V.
  • LG Electronics Inc.
  • Merck & Co., Inc.
  • Natus Medical Incorporated
  • Novartis AG
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi S.A.
  • SleepMed Inc.
  • Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Sleep Aids - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Stress Levels and Insomnia Prevalence Propel Demand for Over-the-Counter Sleep Aids
    • Aging Population with Chronic Sleep Disorders Strengthens Market for Prescription Products
    • Shift Toward Non-Habit Forming and Natural Sleep Aids Expands Consumer Base
    • Integration of Sleep Aids With Smart Devices and Wearables Drives Technology-Enhanced Solutions
    • Widening Acceptance of Cognitive Behavioral Therapy (CBT) for Insomnia Spurs Digital Sleep Aid Adoption
    • Growth of E-Commerce and Direct-to-Consumer Models Expands Product Accessibility
    • Increased Awareness Around Sleep Hygiene Fuels Demand for Supplement-Based Sleep Aids
    • Innovations in Melatonin and Herbal Formulations Sustain Product Differentiation
    • Mental Health Integration in Wellness Programs Drives Cross-Sector Sleep Aid Demand
    • Employer Wellness Initiatives and Corporate Health Plans Create Institutional Opportunities
    • Rising Prevalence of Shift Work Sleep Disorder Expands Target Demographics
    • Celebrity Endorsements and Lifestyle Branding Enhance Market Visibility
    • Health Insurance Support in Some Markets Strengthens Prescription Sleep Aid Sales
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sleep Aids Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sleep Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sleep Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Medications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Medications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sleep Apnea Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sleep Apnea Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sleep Apnea Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Mattresses & Pillows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Mattresses & Pillows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Mattresses & Pillows by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Insomnia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Insomnia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Insomnia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Sleep Apnea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Sleep Apnea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Sleep Apnea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Restless Legs Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Restless Legs Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Restless Legs Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Night Terrors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Night Terrors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Night Terrors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Sleep Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • JAPAN
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • CHINA
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • EUROPE
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sleep Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Sleep Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • FRANCE
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • GERMANY
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Sleep Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Sleep Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • INDIA
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Sleep Aids by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Sleep Aids by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Sleep Aids by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Sleep Aids by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Sleep Aids by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030
  • AFRICA
    • Sleep Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Sleep Aids by Product Type - Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Sleep Aids by Product Type - Percentage Breakdown of Value Sales for Medications, Sleep Apnea Devices, Mattresses & Pillows and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Sleep Aids by Sleep Disorder - Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Sleep Aids by Sleep Disorder - Percentage Breakdown of Value Sales for Insomnia, Sleep Apnea, Restless Legs Syndrome, Night Terrors and Other Sleep Disorders for the Years 2015, 2025 & 2030

IV. COMPETITION